Jeongyeon Hwang, Luisa F. Figueredo, Daphne I. Valencia, Thomas M. Tolbert, Eriko Hamada, Li Zhou, Joshua L. Gills, Joaquin Ruiz, Katarina R. Martillo, Sarah S. Chu, Ankita Kumar, Esther M. Blessing, Omonigho M. Bubu, Ankit Parekh, Korey Kam, Anna E. Mullins, David M. Rapoport, Indu Ayappa, Ricardo S. Osorio, Andrew W. Varga
{"title":"Longitudinal associations of rapid eye movement (REM) sleep and slow‐wave sleep with plasma Alzheimer's disease biomarkers","authors":"Jeongyeon Hwang, Luisa F. Figueredo, Daphne I. Valencia, Thomas M. Tolbert, Eriko Hamada, Li Zhou, Joshua L. Gills, Joaquin Ruiz, Katarina R. Martillo, Sarah S. Chu, Ankita Kumar, Esther M. Blessing, Omonigho M. Bubu, Ankit Parekh, Korey Kam, Anna E. Mullins, David M. Rapoport, Indu Ayappa, Ricardo S. Osorio, Andrew W. Varga","doi":"10.1002/alz.71910","DOIUrl":null,"url":null,"abstract":"INTRODUCTION Data on how sleep architecture relates to progression of plasma Alzheimer's disease biomarkers remains limited. METHODS Sixty‐four cognitively unimpaired older adults (ages 55–90) underwent plasma collection twice 2.6 years apart and polysomnography proximate to the first plasma collection. Plasma amyloid beta (Aβ) 42 and 40 were measured via mass spectrometry. RESULTS Frontal slow‐wave activity (SWA) was inversely associated with plasma Aβ42/40 at cross‐section in bivariate analysis and in a covariate‐adjusted model. In comparison, low rapid eye movement (REM) sleep percentage was associated with a large longitudinal decline in annualized blood‐based Aβ42/40. In exploratory analyses, the association between low REM sleep percentage and faster decline in Aβ42/40 ratio was stronger in the amyloid‐positive group. DISCUSSION In cognitively unimpaired older adults, non‐REM SWA correlates with cross‐sectional amyloid load, whereas REM sleep may predict accelerated amyloid accumulation in preclinical stage, suggesting both may serve as early biomarkers and modifiable interventional targets.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"38 1","pages":""},"PeriodicalIF":12.8000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/alz.71910","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
INTRODUCTION Data on how sleep architecture relates to progression of plasma Alzheimer's disease biomarkers remains limited. METHODS Sixty‐four cognitively unimpaired older adults (ages 55–90) underwent plasma collection twice 2.6 years apart and polysomnography proximate to the first plasma collection. Plasma amyloid beta (Aβ) 42 and 40 were measured via mass spectrometry. RESULTS Frontal slow‐wave activity (SWA) was inversely associated with plasma Aβ42/40 at cross‐section in bivariate analysis and in a covariate‐adjusted model. In comparison, low rapid eye movement (REM) sleep percentage was associated with a large longitudinal decline in annualized blood‐based Aβ42/40. In exploratory analyses, the association between low REM sleep percentage and faster decline in Aβ42/40 ratio was stronger in the amyloid‐positive group. DISCUSSION In cognitively unimpaired older adults, non‐REM SWA correlates with cross‐sectional amyloid load, whereas REM sleep may predict accelerated amyloid accumulation in preclinical stage, suggesting both may serve as early biomarkers and modifiable interventional targets.
期刊介绍:
Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.